Bristol-Myers Squibb Rights
CELG.RT
20 hedge funds and large institutions have $6.42M invested in Bristol-Myers Squibb Rights in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
219% more capital inflows, than outflows
Capital inflows: $25.3K | Capital outflows: $7.94K
0.02% more ownership
Funds ownership: 0.03% → 0.05% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
5% less funds holding
Funds holding: 21 → 20 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Murchinson
Toronto,
Ontario, Canada
|
+$20K |
| 2 |
Maven Securities
St Helier,
Jersey
|
+$3.4K |
| 3 |
Two Sigma Securities
New York
|
+$520 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.44K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.8K |
| 3 |
Trivium Point Advisory
Westport,
Connecticut
|
-$600 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$83 |
| 5 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$8 |
CELG.RT Hedge Fund Activity: Q4 2024 in Review
20 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q4 2024, worth a combined $6.42M — up 24% from $5.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CELG.RT and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Murchinson, opening a new position worth an estimated $20K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $5.44K sold.
- 20 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q4 2024, down from 21 in Q3 2024.
- Funds reported $6.42M of Bristol-Myers Squibb Rights stock for Q4 2024, up 24% quarter-over-quarter.
- 3 funds opened new Bristol-Myers Squibb Rights positions in Q4 2024 and 4 closed out, a net change of -1 holder.
- The largest Bristol-Myers Squibb Rights buyer in Q4 2024 was Murchinson, an estimated $20K added.
- The largest Bristol-Myers Squibb Rights seller in Q4 2024 was Susquehanna International Group, an estimated $5.44K sold.
Based on aggregated 13F filings for Q4 2024.